It Is My Opinion That S.O.T. Is A Better Choice For Cancer Patients
Check With A Doctor Listed At The Link Below
For S.O.T. Information:Click Here
What Is GcMAF & How Does It Work?
GcMAF (Gc Protein derived Macrophage Activating Factor) occurs naturally in our bodies and instructs macrophages to destroy cancerous cells and foreign invaders by activating them. In a healthy person, GcMAF acts as the “commanding officer” of the immune system, and also instructs macrophages in the bloodstream to kill malignancies. But viruses and malignant cells like cancer send out an enzyme called nagalase that neutralizes the GcMAF. This means the macrophages never get the message to go into action in this way diseases become chronic by suppressing the immune system, and cancer cells grow unchecked.
To reverse this, GcMAF can be extracted and purified. It is then given to the patient one dose a week for about 24 weeks for early cancers and about a year for later stage cancers. In its role of immune system regulator, research shows GcMAF can reverse diseases that attack the immune system and various types of Immune dysfunction.
What Has Been Learned About GcMAF?
The many scientists who have published papers on trials of GcMAF worked with patients with early stage cancer and HIV, and reported nearly 100% success, with no recurrence after many years. These trials did not include patents with large tumors.
Other studies have been done since on patents over 50, some over 80, with advanced or terminal cancers, with significant tumor mass.
It has been shown that patients with chronic herpes/acne take about six weeks to respond to treatment. Patients with Autism show an 85% response rate, CFS or HIV show a 15% response rate, and patients with stage 1 or 2 cancer show an 80% response rate in 24 weeks. Late stage cancer shows a 20% response rate after a year to 18 months. The more minor the disease, the easier it is for GcMAF and one's immune system to eradicate the disease. GcMAF needs normal levels of vitamin D to function strongly. But even in low responders, GcMAF usually appears to stop the advancement of cancer.
Studies have shown that GcMAF can work for people up to the age of 90, with terminal stage 4 cancer, and can destroy large tumor mass.
Patients should have their blood taken for monocyte counts, relevant markers and vitamin D levels, and for nagalase at the beginning of treatment, again after three weeks, and again after eight weeks. At eight weeks there should be a significant drop in nagalase which will indicate the disease is losing its grip. Finally when nagalase gets below 0.65 it loses the ability to prevent the body from producing its own GcMAF. The body will then begin to produce its own GcMAF.
Autistic children can improve at five weeks with substantial improvements at eight weeks.
The beauty of using one's own immune system to attack cancer is that it remembers how to defeat it for the rest of one's life: it does not come back. And unlike chemotherapy, the side effects are trivial.
GcMAF Information: GcMaf The Book